🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purposes of the study is to determine the safety and efficacy of human ...
Status
Suspended
Location
Inner Mongolia International Mongolian Hospital
Start Date
2026-12-31
Trial ID
NCT03184935
Treatments Being Tested
To study if decitabine can help to control Myelodysplastic Syndrome (MDS) i...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2005-03
Trial ID
NCT00113321
Treatments Being Tested
To explore the safety, tolerability, and clinical effects of decitabine com...
Status
Unknown
Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Start Date
2018-06-01
Trial ID
NCT03558412
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of avaprit...
Status
Recruiting
Location
First Affiliated Hospital Of University of Science and Technology of China
Start Date
2024-03-01
Trial ID
NCT06316960
Background: Non-small cell lung cancer (NSCLC) is the most common type of ...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2018-04-11
Trial ID
NCT03233724
Treatments Being Tested
Primary: To determine the maximum tolerated dose and schedule of decitabin...
Status
Completed
Location
Washington University School of Medicine
Start Date
2009-12
Trial ID
NCT00986804
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested
This study is investigating whether adding dexamethasone, an anti-inflammat...
Status
Enrolling By Invitation
Location
University of Vermont Medical Center
Start Date
2025-09-01
Trial ID
NCT07014462
Treatments Being Tested
Allogeneic haematopoietic stem cell transplantation (allo-HSCT) remains one...
Status
Unknown
Location
Peking University Institute of Hematology,Beijing
Start Date
2018-12-01
Trial ID
NCT03799224
Treatments Being Tested
Patients with relapsed/refractory diffuse large B cell lymphoma with extran...
Status
Unknown
Location
ChinaPLAGH
Start Date
2023-05-15
Trial ID
NCT05816746
Treatments Being Tested